肿瘤干细胞异质性的综述cell

肿瘤干细胞异质性的综述cellLeadingEdgeEssay822Cell138,September4,2022?2022ElsevierInc.WhatIstheCancerStemCellModel?Todevisemoreeffectivecancerther-apiesitwillbecriticaltodeterminewhichcancercellshavethepotentialtocontributetodiseaseprogression.Ifmostcancercellscanproliferateexten-sivelyandmetastasize,thenvirtuallyallcellsmustbeeliminatedtocurethedisease.Consistentwiththisview,tra-ditionalcancertherapieshavesoughttoeliminateasmanycancercellsaspossible.Incontrasttothisapproach,thecancerstemcellmodelproposesthatthegrowthandprogressionofmanycancersaredrivenbysmallsub-populationsofcancerstemcells(Reyaetal.,2001;Dick,2022).Thecancerstemcellmodeldoesnotaddressthequestionofwhethercancersarisefromnormalstemcells.Rather,itsuggeststhatirrespectiveofthecell-of-origin,manycancersmaybehierarchicallyorganizedinmuchthesamemannerasnormaltissues.Justasnormalstemcellsdifferentiateintophenotypicallydiverseprogenywithlimitedprolifera-tivepotential,itisarguedthatcancerstemcellsalsoundergoepigeneticchangesanalogoustothedifferentia-tionofnormalcells,formingphenotyp-icallydiversenontumorigeniccancercellsthatcomposethebulkofcellsinatumor.Theseepigeneticchangesareproposedtobeassociatedwithanirreversible(orrarelyreversible)lossoftumorigeniccapacitysuchthatthevastmajorityofcellsinthesecancershavelittlecapacitytocontributetodis-easeprogression.Tocharacterizeandeliminatethemalignantcellsincancersthatfollowthismodel,itisnecessarytofocusonthesmallsubpopulationsoftumorigeniccells.Consistentwiththecancerstemcellmodel,certaincancers(includingsomegermcellcancersandsomeleukemias)havebeenrecognizedfordecadestoincludeneoplasticcellsthatdifferenti-ateintopost-mitoticderivatives.Germcellcancersgiverisetohighlydiffer-entiatedcells,suchasthosethatmakeneuraltissue(IllmenseeandMintz,1976).Someleukemiasgiverisetohighlydifferentiatedhematopoieticcells(Fearonetal.,11016;Barabeetal.,2007).Thesecancersareobviouslyhierarchicallyorganized.Themorecontroversialquestionraisedbyrecentstudiesiswhethermanyothercancersexhibitasimilarhierarchicalorganiza-tion,evenwhenovertdifferentiationisnotevidentamongthecancerhttps://www.sodocs.net/doc/7d9770465.htmlpellingdatasupportthecan-cerstemcellmodelinvarioushumancancersincludingmalignantgermcellcancers(KleinsmithandPierce,1964;IllmenseeandMintz,1976),leu-kemias(Lapidotetal.,11014;BonnetandDick,11017),breastcancers(Al-Hajjetal.,2003),braincancers(Singhetal.,2004),andcoloncancers(Dal-erbaetal.,2007;O’Brienetal.,2007;Ricci-Vitianietal.,2007).Ineachcase,onlysmallsubpopulationsofcellscantransferdiseaseupontransplantationintoimmunocompromisedNOD/SCIDmice,andmarkershavebeenidentifiedthatdistinguishtheleukemogenic/tum-origeniccancercellsfromthebulkpop-ulationsofnonleukemogenic/tumori-geniccells.Theabilitytopredictwhichcellsaretumorigenicbasedonmarkerexpressionindicatesthatthetumori-geniccellsareintrinsicallydifferentfromnontumorigeniccancercells.Yet,noclearmorphologicaldistinctionwasfoundbetweentumorigenicandnontu-morigenicbreastcancercells(Al-Hajjetal.,2003),implyingthatdifferentia-tionneednotbeovertforthecellstobehierarchicallyorganized.Theobserva-tionthattumorigeniccellshavetendedtoberareinthecancersfoundsofartofollowacancerstemcellmodelimpliesthatepigeneticdifferencesdistinguishtumorigenicfromnontumorigeniccellsbecauseitisimplausiblethatonlyrarecancercellshaveagenotypepermis-siveforextensiveproliferation.Tum-origeniccancerstemcellsalsoformphenotypicallydiversenontumorigeniccells,recapitulatingatleastsomeoftheheterogeneityinthetumorsfromwhichtheyderive.Despitestrongdatasupportingthestemcellmodelinsomecancers,itisimportanttoacknowledgeanumberofcaveats.Thereisnodirectevidenceinthesecancersthattumorigeniccellsdifferfromnontumorigeniccellsasaresultofepigeneticratherthangeneticdifferences.Moreover,theconclusionthattransplantedcancerstemcellsHeterogeneityinCancer:CancerStemCellsversusClonalEvolutionMarkShackleton,1ElsaQuintana,1EricR.Fearon,2andSeanJ.Morrison1,2,*1HowardHughesMedicalInstitute,LifeSciencesInstitute,CenterforStemCellBiology2DepartmentofInternalMedicineUniversityofMichigan,AnnArbor,MI48109,USA*Correspondence:seanjm@https://www.sodocs.net/doc/7d9770465.htmlDOI10.1016/j.cell.2022.08.017Theidentificationandcharacterizationofcancerstemcellsmightleadtomoreeffectivetreat-mentsforsomecancersbyfocusingtherapyonthemostmalignantcells.Toachievethisgoalitwillbenecessarytodeterminewhichcancersfollowacancerstemcellmodelandwhichdonot,toaddresstechnicalissuesrelatedtotumorigenesisassays,andtotesttheextenttowhichcancercellheterogeneityarisesfromgeneticversusepigeneticdifferences.本文来源:网络收集与整理,如有侵权,请联系作者删除,谢谢!

1、当您付费下载文档后,您只拥有了使用权限,并不意味着购买了版权,文档只能用于自身使用,不得用于其他商业用途(如 [转卖]进行直接盈利或[编辑后售卖]进行间接盈利)。
2、本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供参考,付费前请自行鉴别。
3、如文档内容存在侵犯商业秘密、侵犯著作权等,请点击“举报”。

常见问题具体如下:

1、问:已经付过费的文档可以多次下载吗?

      答:可以。登陆您已经付过费的账号,付过费的文档可以免费进行多次下载。

2、问:已经付过费的文档不知下载到什么地方去了?

     答:电脑端-浏览器下载列表里可以找到;手机端-文件管理或下载里可以找到。

            如以上两种方式都没有找到,请提供您的交易单号或截图及接收文档的邮箱等有效信息,发送到客服邮箱,客服经核实后,会将您已经付过费的文档即时发到您邮箱。

注:微信交易号是以“420000”开头的28位数字;

       支付宝交易号是以“2024XXXX”交易日期开头的28位数字。

客服邮箱:

biganzikefu@outlook.com

所有的文档都被视为“模板”,用于写作参考,下载前须认真查看,确认无误后再购买;

文档大部份都是可以预览的,笔杆子文库无法对文档的真实性、完整性、准确性以及专业性等问题提供审核和保证,请慎重购买;

文档的总页数、文档格式和文档大小以系统显示为准(内容中显示的页数不一定正确),网站客服只以系统显示的页数、文件格式、文档大小作为依据;

如果您还有什么不清楚的或需要我们协助,可以联系客服邮箱:

biganzikefu@outlook.com

常见问题具体如下:

1、问:已经付过费的文档可以多次下载吗?

      答:可以。登陆您已经付过费的账号,付过费的文档可以免费进行多次下载。

2、问:已经付过费的文档不知下载到什么地方去了?

     答:电脑端-浏览器下载列表里可以找到;手机端-文件管理或下载里可以找到。

            如以上两种方式都没有找到,请提供您的交易单号或截图及接收文档的邮箱等有效信息,发送到客服邮箱,客服经核实后,会将您已经付过费的文档即时发到您邮箱。

注:微信交易号是以“420000”开头的28位数字;

       支付宝交易号是以“2024XXXX”交易日期开头的28位数字。

确认删除?